Daily Position Changes Report for ARK Innovation ETF (ARKK)
Date: January 30, 2026
Overview
On January 30, 2026, the ARK Innovation ETF (ARKK) maintained its positions without any notable changes in its holdings. The ETF continues to be heavily invested in technology and biotech sectors, with Tesla Inc (TSLA) leading the portfolio.
Detailed Summary
The ARKK ETF's holdings as of January 30, 2026, reflect a stable investment strategy, with no changes in shares or values compared to the previous day. The top holdings include Tesla Inc, CRISPR Therapeutics AG, and Roku Inc, which collectively represent a significant portion of the ETF's total value. The fund's focus remains on innovation-driven companies, particularly in the tech and healthcare sectors.
Analysis and Interpretation
The lack of trading activity suggests a strategic pause by ARK Invest, possibly indicating confidence in their current holdings amidst market fluctuations. This approach may allow the fund to consolidate its positions, especially in high-growth sectors that are expected to rebound. The consistent weight of Tesla Inc at 10.302% indicates its critical role in ARKK's investment strategy.
Summary Table of Holdings (January 30, 2026)
| Ticker | Company Name | Weight (%) | Estimated Trade Value ($) |
|---|---|---|---|
| TSLA | Tesla Inc | 10.302 | 755,538,534.40 |
| CRSP | CRISPR Therapeutics AG | 5.457 | 400,182,221.35 |
| ROKU | Roku Inc-A | 5.316 | 389,886,600.00 |
| TEM | Tempus AI Inc-A | 5.128 | 376,052,962.98 |
| COIN | Coinbase Global Inc-A | 4.746 | 348,032,387.88 |
| SHOP | Shopify Inc-A | 4.129 | 302,813,482.86 |
| BEAM | Beam Therapeutics Inc | 3.653 | 267,899,671.70 |
| PLTR | Palantir Technologies Inc | 3.461 | 253,782,530.77 |
| TWST | Twist Bioscience Corp | 2.528 | 185,406,472.90 |
| TXG | 10x Genomics Inc-A | 2.286 | 167,671,822.50 |
This report will be updated with new data on the following trading day. Please let me know if you need any additional information or analysis.
Explore more exclusive insights at nextfin.ai.